Clinical Effects of Temperature Controlled Laminar Airflow (TLA)

NCT00987064 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Perennial Allergy

Interventions

DEVICE: Temperature controlled Laminar Airflow (Protexo)
DEVICE: Placebo TLA

Sponsor

Airsonett AB

Collaborators

[object Object]
[object Object]
[object Object]